The Current Ratio of Emergent BioSolutions Inc. (EBS) is
5.01.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date |
Value |
| 2025-12-31 |
5.01
|
| 2024-12-31 |
3.69
|
| 2023-12-31 |
1.04
|
| 2022-12-31 |
0.98
|
| 2021-12-31 |
3.40
|
| 2020-12-31 |
3.11
|
| 2019-12-31 |
3.17
|
| 2018-12-31 |
3.10
|
| 2017-12-31 |
4.85
|
| 2016-12-31 |
4.82
|
| Ticker |
Name |
Value |
|
IOVA
|
Iovance Biotherapeutics Inc
|
3.20
|
|
SRPT
|
Sarepta Therapeutics, Inc.
|
2.32
|
|
IRWD
|
Ironwood Pharmaceuticals, Inc.
|
1.13
|
|
RLAY
|
Relay Therapeutics, Inc.
|
22.61
|
|
FOLD
|
Amicus Therapeutics Inc
|
2.84
|
|
SWTX
|
SpringWorks Therapeutics, Inc.
|
3.81
|
|
BHVN
|
Biohaven Ltd.
|
3.18
|
|
BLUE
|
Genetix Biotherapeutics Inc
|
0.48
|
|
GBT
|
Global Blood Therapeutics Inc
|
9.11
|
|
UTHR
|
United Therapeutics Corporation
|
6.60
|
|
CCXI
|
Churchill Capital Corp XI
|
8.13
|
|
DRNA
|
Dicerna Pharmaceuticals Inc
|
3.48
|
|
FGEN
|
FibroGen Inc
|
1.47
|
|
ARNA
|
Arena Pharmaceuticals Inc
|
8.59
|
|
SANA
|
Sana Biotechnology, Inc.
|
1.89
|
|
LEGN
|
Legend Biotech Corporation
|
1.96
|
|
APLS
|
Apellis Pharmaceuticals, Inc.
|
3.14
|
|
HALO
|
Halozyme Therapeutics, Inc.
|
4.66
|
|
IONS
|
Ionis Pharmaceuticals, Inc.
|
3.83
|
|
KOD
|
Kodiak Sciences Inc.
|
4.72
|
|
RVMD
|
Revolution Medicines, Inc.
|
7.14
|
|
LGND
|
Ligand Pharmaceuticals Incorporated
|
22.23
|
|
NTLA
|
Intellia Therapeutics, Inc.
|
5.08
|
|
TPTX
|
Turning Point Therapeutics Inc
|
21.08
|
|
ALKS
|
Alkermes Plc
|
3.55
|
|
ALLO
|
Allogene Therapeutics, Inc.
|
7.93
|
|
BPMC
|
Blueprint Medicines Corp
|
2.85
|